Odylia is a unique nonprofit biotech bringing life-changing treatments to people with rare genetic disorders, regardless of prevalence or commercial interest. We help groups navigate the complexity of bringing treatments from the lab to patients.
Odylia is recreating how treatments can be brought to patients with rare disease. By building innovative partnerships and unique solutions, we are changing the paradigm of drug development for rare disease.
With little commercial interest in treatments for rare disease, Odylia relies on contributions from individuals, other nonprofit organizations, patient groups, and corporate donors to bring life-changing treatments to patients. Learn more about how you can make a difference.